<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02487680</url>
  </required_header>
  <id_info>
    <org_study_id>DoubleGood Lund</org_study_id>
    <nct_id>NCT02487680</nct_id>
  </id_info>
  <brief_title>Effects of an Amino Acid and Chromium-picolinate Containing Drink on Glucose Metabolism on Healthy Subjects</brief_title>
  <official_title>Effect of a Table Water Enriched With Amino Acids and Chromium on Blood Glucose and Insulin Levels After a Meal</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>DoubleGood AB</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lund University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>DoubleGood AB</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It has previously been shown in healthy overweight subjects, that table water including a
      defined amount of amino acids and chromium can decrease the postprandial glucose. In this
      study, the effect of this table water on glucose excursions after a test meal containing a
      defined amount of available carbohydrates, protein and fat will be studied in healthy
      subjects. The study will be conducted in a cross -over design, double blinded and placebo
      controlled including 20 participants. The primary endpoint of the study is the incremental
      area under the curve for plasma glucose (iAUCgluc) within 180 minutes after ingestion of the
      meal.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2015</start_date>
  <completion_date type="Actual">November 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Area under the curve for Glucose after ingestion of a test meal</measure>
    <time_frame>180 min</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Area under the curve for insulin after ingestion of a test meal</measure>
    <time_frame>180 min</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Breakfast meal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A breakfast like meal will be provided together with a drink to overnight fasted subjects</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lunch meal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A lunch like meal will be provided together with a drink to overnight fasted subjects</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Amino Acids and chromium-picolinate containing drink</intervention_name>
    <description>Evaluation of the dietary supplement drink containing amino acids and chromium picolinate and aroma</description>
    <arm_group_label>Breakfast meal</arm_group_label>
    <arm_group_label>Lunch meal</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo drink</intervention_name>
    <description>Evaluation of the placebo supplement drink containing only aroma</description>
    <arm_group_label>Breakfast meal</arm_group_label>
    <arm_group_label>Lunch meal</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Stable body weight (no changes above 3 kg during the last 2 months)

          -  Good general health

          -  Body mass index 19 - 30 kg/m2 (normal to overweight)

          -  Fasting blood glucose below 6.1 mmol/L

        Exclusion Criteria:

          -  Any medication that could influence the study. Such as medication against diabetes,
             hypoglycemia, hypertension or hypercholesterolemia

          -  Psychiatric Disease

          -  Alcohol or drug abuse

          -  Smokers or people consuming snus

          -  Acute infections

          -  Vegetarians/vegans

          -  Suffering from Lactose or Gluten intolerance

          -  Pregnancy or Lactation

          -  Participation in another study at the same time

          -  Any other parameter that the PI will judge as inadequate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Per Humpert, MD, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stoffwechselzentrum Rhein Pfalts, Mannheim, Germany and Department of internal medicine, University of Heidelberg, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ana Rasc√≥n, PhD, Prof</last_name>
    <role>Study Director</role>
    <affiliation>Food for Health Science Center, Lund University, Sweden</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kristina Andersson, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Experimental Medical Science, Lund University, Sweden</affiliation>
  </overall_official>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 29, 2015</study_first_submitted>
  <study_first_submitted_qc>June 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 1, 2015</study_first_posted>
  <last_update_submitted>May 11, 2017</last_update_submitted>
  <last_update_submitted_qc>May 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chromium</mesh_term>
    <mesh_term>Picolinic acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

